Seber, Adriana; Castro Junior, Claudio Galvão de; Kerbauy, Lucila N.; Hirayama, Alexandre V.; Bonfim, Carmem; Fernandes, Juliana Folloni 
; Souza, Mair; Schafell, Rony; Nabhan, Samir; Loggetto, Sandra Regina; Simões, Belinda Pinto; Rocha, Vanderson Geraldo ; Lima, Marcos de; Cunha, Renato Luiz Guerino ; Bittencourt, Henrique
Source: Hematology, Transfusion and Cell Therapy. Unidades: FM, FMRP
Subjects: CÉLULAS, LEUCEMIA, LINFOMA, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEBER, Adriana et al. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, v. 43, p. S13-S21, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2021.09.002. Acesso em: 29 jan. 2026.APA
Seber, A., Castro Junior, C. G. de, Kerbauy, L. N., Hirayama, A. V., Bonfim, C., Fernandes, J. F., et al. (2021). Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia. Hematology, Transfusion and Cell Therapy, 43, S13-S21. doi:10.1016/j.htct.2021.09.002NLM
Seber A, Castro Junior CG de, Kerbauy LN, Hirayama AV, Bonfim C, Fernandes JF, Souza M, Schafell R, Nabhan S, Loggetto SR, Simões BP, Rocha VG, Lima M de, Cunha RLG, Bittencourt H. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S13-S21.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.htct.2021.09.002Vancouver
Seber A, Castro Junior CG de, Kerbauy LN, Hirayama AV, Bonfim C, Fernandes JF, Souza M, Schafell R, Nabhan S, Loggetto SR, Simões BP, Rocha VG, Lima M de, Cunha RLG, Bittencourt H. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43 S13-S21.[citado 2026 jan. 29 ] Available from: https://doi.org/10.1016/j.htct.2021.09.002
